Business
Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer
Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"\n \n \n \n Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnbcc{\nBORDER-TOP-COLOR:; BORDER-COLLAPSE: COLLAPSE; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; BORDER-RIGHT-COLOR:\n}\n \n \n \n \n \n \n PR Newswire\n \n \n \n \n \n LAVAL, QC\n \n ,\n \n Oct. 21, 2021\n \n /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (\"Bausch Health\" or the \"Company\") today announced that\n \n Tom Vadaketh\n \n will join the Company as Chief Financial Officer (CFO) for its Bausch Pharma* business effective\n \n Jan. 3, 2022\n \n .\n \n Sam Eldessouky\n \n , current CFO of the Company, will become CFO of Bausch + Lomb contingent and effective upon the closing of the initial public offering (IPO) of Bausch + Lomb, and at that time, Mr. Vadaketh will assume the role of CFO of Bausch Pharma.\n \n \n Mr. Vadaketh has more than 30 years of financial leadership and experience, including nearly 10 years in CFO roles at eResearch Technology Inc., Cambrex Corporation and the Crosby Group, a KKR Company. He also previously spent more than 20 years at Tyco International and Procter & Gamble.\n \n \n \"We are very pleased that Tom will join the leadership team of Bausch Pharma as our CFO. Tom brings a wealth of experience, having served as a CFO at multiple companies and with a strong background in financial management that spans more than 30 years,\" said\n \n Thomas J. Appio\n \n , president, Bausch + Lomb/International, and the appointed chief executive officer of Bausch Pharma contingent and effective upon the closing of the IPO of Bausch + Lomb. \"Tom will play a critical role in helping to shape the future of the Bausch Pharma business when he joins the company in\n \n January 2022\n \n .\"\n \n \n \"I am excited to join Bausch Pharma, which has a well-known reputation for trusted brands in health care,\" said Mr. Vadaketh. \"I look forward to w...